Jazz Pharma Revenue, Profits - JAZZ Quarterly Income Statement

Add to My Stocks
$163.03 $1.1 (0.68%) JAZZ stock closing price Sep 19, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Jazz Pharma stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the JAZZ stock is bound to reflect the impact of the QOQ growth of 12.57%. The operating expenses as shown in the Jazz Pharma profit and loss statement for 2018 Q2 total to $312.57M. This line item shows that the operating expenses has decreased compared with last year. Also check: Jazz Pharma assets and Jazz Pharma free cash flow.

View and download details of revenue and profits for Jazz Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Jazz Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)34.71M33.91M25.25M31.2M28.67M25.06M33.66M24.31M23.98M23.43M
Jazz Pharma Gross Profit
Research & Development Expense56.13M62.66M74.01M122.36M42.15M44.92M44.16M62.79M39.09M40M
Selling General & Admin Expense201.48M260.22M70.08M171.83M132.32M169.92M175.95M150.82M149.35M128.76M
Income Before Depreciation Depletion Amortization208.16M87.8M267.09M86.45M191.22M136.14M142.87M136.25M168.73M143.8M
Depreciation Depletion Amortization54.96M-125.88M-26.18M--22.64M--22.64M
Non Operating Income-4.12M-1.72M-0.86M-2.22M-5.42M-1.46M4.92M-1.38M--0.81M
Interest Expense19.65M20.6M21.43M19.19M18.29M18.84M19.14M18.49M12.12M12.19M
Jazz Pharma Pretax Income
Provision for Income Taxes36.52M19.14M-113.64M1.23M35.51M29.16M26.75M29.12M45.33M34.03M
Investment Gains Losses-0.59M-0.33M-0.37M-0.27M-0.2M-0.16M-0.27M-0.1M--
Other Income----------
Income Before Extraordinaries & Disc Operations92.32M45.99M232.21M63.53M105.6M86.51M116.69M87.15M111.28M74.12M
Extraordinary Items & Discontinued Operations----------
Jazz Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS61.44M61.18M61.19M61.44M61.46M61.18M61.03M61.64M61.83M62.47M
Average Shares used to compute Basic EPS60.18M59.93M59.98M60.11M60.1M59.88M59.93M60.44M60.5M61.14M
Income Before Nonrecurring Items190.99M161.12M157.92M180.02M105.6M86.51M116.69M133.6M111.28M116.81M
Income from Nonrecurring Items-98.67M-115.12M74.29M-116.49M----46.45M--42.69M
Jazz Pharma Earnings Per Share Basic Net
Jazz Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items3.112.632.582.931.721.411.912.161.801.87
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Jazz Pharma stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $500.48M for this quarter of 2018 Q2. Our Jazz Pharma revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Jazz Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the JAZZ income statement, one can check the Jazz Pharma historical stock prices to check how the price has moved with time.

Jazz Pharma Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield